Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Landolfo C, Ceusters J, Valentin L, Froyman W, Van Gorp T, Heremans R, Baert T, Wouters R, Vankerckhoven A, Van Rompuy AS, Billen J, Moro F, Mascilini F, Neumann A, Van Holsbeke C, Chiappa V, Bourne T, Fischerova D, Testa A, Coosemans A, Timmerman D, Van Calster B. Landolfo C, et al. Among authors: van rompuy as. Br J Cancer. 2024 Apr;130(6):934-940. doi: 10.1038/s41416-024-02578-x. Epub 2024 Jan 19. Br J Cancer. 2024. PMID: 38243011
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center.
Pecoraro A, Elst L, Roussel E, Miletić M, Vanthoor J, De Ridder D, Van Rompuy AS, De Cuyper E, Dumez H, De Meerleer G, de Wever L, Goffin K, Van Poppel H, Joniau S, Albersen M. Pecoraro A, et al. Among authors: van rompuy as. Eur Urol Focus. 2024 Jan;10(1):57-65. doi: 10.1016/j.euf.2023.07.003. Epub 2023 Aug 1. Eur Urol Focus. 2024. PMID: 37537111
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
Perrone E, Capasso I, Giannarelli D, Trozzi R, Congedo L, Ervas E, Tarantino V, Esposito G, Palmieri L, Guaita A, van Rompuy AS, Scaglione G, Zannoni GF, Scambia G, Amant F, Fanfani F. Perrone E, et al. Among authors: van rompuy as. Gynecol Oncol. 2024 Dec;191:150-157. doi: 10.1016/j.ygyno.2024.10.010. Epub 2024 Oct 18. Gynecol Oncol. 2024. PMID: 39423552
MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing.
Passemiers A, Tuveri S, Sudhakaran D, Jatsenko T, Laga T, Punie K, Hatse S, Tejpar S, Coosemans A, Van Nieuwenhuysen E, Timmerman D, Floris G, Van Rompuy AS, Sagaert X, Testa A, Ficherova D, Raimondi D, Amant F, Lenaerts L, Moreau Y, Vermeesch JR. Passemiers A, et al. Among authors: van rompuy as. Bioinformatics. 2024 Sep 2;40(9):btae522. doi: 10.1093/bioinformatics/btae522. Bioinformatics. 2024. PMID: 39177091 Free PMC article.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.
De Wispelaere W, Annibali D, Tuyaerts S, Messiaen J, Antoranz A, Shankar G, Dubroja N, Herreros-Pomares A, Baiden-Amissah REM, Orban MP, Delfini M, Berardi E, Van Brussel T, Schepers R, Philips G, Boeckx B, Baietti MF, Congedo L, HoWangYin KY, Bayon E, Van Rompuy AS, Leucci E, Tabruyn SP, Bosisio F, Mazzone M, Lambrechts D, Amant F. De Wispelaere W, et al. Among authors: van rompuy as. Clin Transl Med. 2024 May;14(5):e1655. doi: 10.1002/ctm2.1655. Clin Transl Med. 2024. PMID: 38711203 Free PMC article.
Central necrosis in uterine sarcoma.
De Bruyn C, Taliento C, Van Rompuy AS, Timmerman D, Coosemans A, Van den Bosch T. De Bruyn C, et al. Among authors: van rompuy as. Ultrasound Obstet Gynecol. 2024 Dec;64(6):716-720. doi: 10.1002/uog.27669. Ultrasound Obstet Gynecol. 2024. PMID: 38669593 No abstract available.
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Ottenbourgs T, van Gorp T, Kridelka F, Baert T, Denys H, Selle F, Baas I, Van Rompuy AS, Lambrechts D, Van Nieuwenhuysen E. Ottenbourgs T, et al. Among authors: van rompuy as. Int J Gynecol Cancer. 2024 Apr 1;34(4):627-630. doi: 10.1136/ijgc-2023-005189. Int J Gynecol Cancer. 2024. PMID: 38453176 Free PMC article. Clinical Trial.
Correction to: Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles.
Bartosch C, Nadal A, Braga AC, Salerno A, Rougemont AL, Van Rompuy AS, Fitzgerald B, Joyce C, Allias F, Maher GJ, Turowski G, Tille JC, Alsibai KD, Van de Vijver K, McMahon L, Sunde L, Pyzlak M, Downey P, Wessman S, Patrier S, Kaur B, Fisher R. Bartosch C, et al. Among authors: van rompuy as. Virchows Arch. 2024 Mar;484(3):539-548. doi: 10.1007/s00428-023-03715-2. Virchows Arch. 2024. PMID: 38421406 No abstract available.
47 results